1 / 29

Pharmacodynamics : Drug Action

Topic 8. Pharmacodynamics : Drug Action. 713 311 PRINCIPLES OF VETERINARY PHARMACOLOGY Dr. Korawuth Punareewattana. Faculty of Veterinary Medicine, Khon Kaen University. Drug Action. Topics in Drug action Sequences of Drug action Primary Responses Action, effect and response

otylia
Download Presentation

Pharmacodynamics : Drug Action

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Topic 8 Pharmacodynamics: Drug Action 713 311 PRINCIPLES OF VETERINARY PHARMACOLOGY Dr. Korawuth Punareewattana Faculty of Veterinary Medicine, Khon Kaen University

  2. Drug Action Topics in Drug action • Sequences of Drug action • Primary Responses • Action, effect and response • Secondary Responses • Classification of Drug action • Based on receptor • Receptor mediated • Agonist or Antagonist • Non-receptor mediate • Based on time course of drug action • Immediate, Delayed, Accumulation

  3. Sequences of Drug action • Primary response • Direct effect and consequences of a drug • Action - > Effect - > Response • e.g. Drug A activate beta receptor on heart muscle • Effect -> increased heart rate, increased cardiac output • Secondary response • Any response of the body system that is induced by primary response • It may either enhance or diminish the primary response • e.g. Primary response of Drug A (Increased cardiac output) • Effect - > Increased GFR Increased rate of excretion

  4. Sequences of Drug actionPrimary Response • Drug Action (Mechanism of action) • on a receptor • Drug Effect • observable consequence of drug action (“biomarker”, “surrogate endpoint”) • Drug Response • clinical outcome

  5. Example:Thiopentonean ultra-short iv anesthetic agent • Drug Action • Potentiation of GABA receptor activation • Drug Effect • Slowing of EEG activity • Drug Response • Anesthesia

  6. Classification of Drug actionBased on Receptors • Receptor mediated Drug action • Receptors • Ligands (Drugs) • Ligand-receptor interaction  effect • Non-receptor mediated Drug action • Physical property  effect • Chemical property  effect

  7. Non-receptor mediated drug action • For a minority of drugs • PD properties are determined by some physico-chemicalproperty • The mechanisms are characterized by a lack of requirement for highly specific chemical structure • Examples • Bulk or Osmotic laxatives • Osmotic diuretics • Volatile liquids • Emollient creams • Antacids

  8. Examples of Non-receptor mediated drug action • Bulk or Osmotic laxatives • MgSO4 draw fluid into GI tract • Osmotic diuretics • Mannitol increase osmotic pressure in urine • Volatile liquids • Ethyl Chloride – sprayed on skin – evaporate - cool

  9. Examples of Non-receptor mediated drug action • Emollient creams • Physical protective barrier • Antacids • Sodium bicarbonate neutralize excess acid in the stomach

  10. Receptor-mediated Drug action • For majority of drugs, Drug action will be either • Mimic or inhibit normal physiological / biochemical processes or inhibit pathological processes in animals • Inhibit vital processes of endo- or ectoparasites and microbial organisms • (Theactions will give results asPharmacological effects) • The action is mediated by • the interaction or chemical binding between drug and molecules (receptors) in body tissues, parasites, or microorganisms.

  11. Receptor-mediated Drug action • The actions are produced by mechanisms • Which are similar or identical to those mechanisms • By which enzymes interact with substrate or • By which neurotransmitters or hormones produce their biological effects • The action can be either increase, decrease, or inhibit the physiological process • Depending on the type and quantity of ligands or drugs • Agonist • Partial agonist • Antagonist

  12. Example ofReceptor-mediated Drug actionCardiovascular effect of the catecholamines The catecholamines (Epinephrine, Norepinephrine) • Molecular level • Interact with 1-receptor • -> increase cAMP • -> increase slope of the depolarization potential • Cellular level • The action potential generated • -> Wave of electrical conduction • -> increase rate of firing of the sinus node cells • -> increase contractility of the myocardial cells

  13. Example ofReceptor-mediated Drug actionCardiovascular effect of the catecholamines • Tissue level • Increase heart rate • Increase heart contractility • -> increase cardiac output • System level • Increase blood supply to the heart, brain and muscle

  14. Classification of Drug actionTime Course of Drug Action • Immediate Drug Effects • Delayed Drug Effects • Cumulative Drug Effects

  15. Immediate Drug EffectsThiopentone Distribution to Effect Site in Brain • Drug Action • Potentiation of GABA receptor activation • Drug Effect • Slowing of EEG activity • Drug Response • Anesthesia • Response in Minutes

  16. Thiopentone Time Course

  17. Delayed Drug Effects • Distribution to Effect Site • pharmaco-kinetics • “effect compartment model” • Physiological Intermediate • physio-kinetics • “indirect effect model”

  18. Delayed Drug EffectsWarfarin Physiological Intermediate • Drug Action • inhibition of Vit K recycling • Drug Effect • decreased synthesis of clotting factors • Drug Response • prolonged coagulation time

  19. Physiokinetic Delayed ResponseWarfarin and The Vitamin K Cycle

  20. Warfarin Delayed Response • IC50 for synthesis is 1.5 mg/L • Synthesis is reduced 50% at the IC50 • [prothrombin complex] is reduced 50% • Critical parameter is • Half-life of prothrombin complex • about 14 h • Takes 4 half-lives to reach SS • 2 to 3 days

  21. Physiokinetic Delayed Responses • Angiotension Converting Enzyme Inhibitors (enalapril) • Delayed effect on blood pressure (1 week) • Half-life of Na+ is about 2 days • Anti-Depressants (amitriptyline) • Delayed effect on depression (2 weeks) • Unidentified mediator • A protein with a 4 day half-life?

  22. Cumulative Drug Response • Response is related to drug exposure • Exposure Indicators • Single Dose • Daily Dose Rate • Cumulative Dose • Average Steady State Conc (Css) • Area under Time vs Conc Curve (AUC) • Area under Time vs Effect Curve (AUCe)

  23. Cumulative Drug EffectsAcid Pump Inhibitors • Action • inhibition of gastric acid pump • Effect • decreased acid secretion and increased pH • Response • ulcer healing

  24. Cumulative Drug EffectsUlcer Healing Response • Takes several weeks of acid inhibition to heal an ulcer • Acid inhibition Effect is constant but the Response continues to develop (e.g. smaller size of ulcer) • Response time course is (almost) independent of drug dose/concentration when inhibition is nearly 100%

  25. Cumulative Drug EffectsDiuretics and Heart Failure • Diuretics are used to treat heart failure • with digoxin and ACE inhibitors • Symptoms are produced by excess fluid • Ascites, edema, breathlessness, ankle swelling, (dropsy) • Benefit is related to net reduction in fluid

  26. Cumulative Drug EffectsDiuretic Action/Effect/Response • Action • Inhibition of Na+ reabsorption • Effect • Increased Na+ and H2O excretion • Cumulative fluid loss • Response • Reduced ankle swelling • Decreased breathlessness

  27. Cumulative Drug EffectsSchedule Dependence • Response is NOT proportional to cumulative diuretic doseor AUC • Response IS proportional to cumulative diuretic effector AUCe • Phenomenon is known as • “Schedule Dependence”

  28. Furosemide Response • 40 mg x 3 • AUCe = 540 mmol Na+/12h • 120 mg x 1 • AUCe = 400 mmol Na+ /12h • Response is increased 35% • using 40 mg x 3

  29. Cumulative Drug EffectsAnti-Cancer Agents • Schedule Dependence is common • Large intermittent doses are often more toxic and less effective than smaller repeated doses • Response is related to cumulative dose as well as Schedule • AUC may be used to guide individual treatment • Action • Irreversible binding to cell structure • Effect • Block of cell division/cell death • Slowing or reversal of tumour growth • Response • Decreased morbidity (e.g. Pain) • Postponement of death

More Related